At a glance
A pharmaceutical company focused on the development of liposomal therapeutics for the treatment of cancer. Its flagship product LC 101 is FDA-approved for treatment of ovarian cancer, multiple myeloma and AIDS-related Kaposi’s sarcoma. Product was launched in the US by Padagis (Perrigo) in Oct 2021
MORE COMPANIES
